BioCentury
ARTICLE | Clinical News

Sanguinate regulatory update

April 13, 2015 7:00 AM UTC

Prolong said FDA granted Orphan Drug designation to Sanguinate to treat sickle cell disease (SCD). Sanguinate is a pegylated carboxyhemoglobin bovine that functions as a carbon monoxide-releasing mole...